Drug shortage
Methylprednisolone Acetate Injection · Amneal Pharmaceuticals
FDA drug shortage · Current · updated Apr 2, 2025
Key facts
| Generic name | Methylprednisolone Acetate Injection |
|---|---|
| Proprietary name | Methylprednisolone Acetate |
| Company | Amneal Pharmaceuticals |
| Presentation | Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 70121-1573-1) |
| Dosage form | Injection |
| Strength | 40 mg/1 mL |
| Status | Current |
| Therapeutic category | Rheumatology |
| Package NDCs | 70121-1573-1 |
| First posted | Dec 15, 2021 |
| Last updated | Apr 2, 2025 |
At a glance
- 1–9 Package NDCs affected
- 10–99 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: